News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
192 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2722)
February (2862)
March (3369)
April (3287)
May (3419)
June (3649)
July (3258)
August (3461)
September (3585)
October (3789)
November (3817)
December (2398)
Day
1 (152)
2 (136)
3 (91)
6 (192)
7 (159)
8 (144)
9 (142)
10 (104)
13 (133)
14 (149)
15 (136)
16 (126)
17 (88)
20 (134)
21 (98)
22 (115)
27 (125)
28 (61)
29 (54)
30 (59)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
6
7
8
9
10
13
14
15
16
17
20
21
22
27
28
29
30
Drug Development
S*Bio’s Novel JAK2 Inhibitor SB1518 Is Shown to Be a Safe and Effective Therapy in Phase 1/2 Studies For Patients with Symptomatic Myelofibrosis and Relapsed/Refractory Lymphoma
December 6, 2010
·
6 min read
Pharm Country
Regeneron Pharmaceuticals, Inc. Announces Presentation at the 2010 Deutsche Bank BioFest
December 6, 2010
·
1 min read
Business
Biodel Inc. to Report Fourth Quarter Fiscal Year 2010 Financial Results on December 9, 2010
December 6, 2010
·
1 min read
Biotech Bay
diaDexus to Present at the Canaccord Genuity Healthcare Conference
December 6, 2010
·
1 min read
Deals
Clarient, Inc. Tender Offer Extended; Clarient Makes Additional Disclosures to Settle Litigation
December 6, 2010
·
6 min read
Drug Development
Cell Therapeutics, Inc.: New Pixantrone Data Presented at Meetings at American Society of Hematology Conference
December 6, 2010
·
8 min read
Genetown
Insulet Corporation to Present at the Canaccord Adams 5th Annual Cardiovascular, Diabetes and Obesity Conference
December 6, 2010
·
1 min read
Drug Development
H. Lundbeck A/S Says Clobazam Effective In Seizures in Phase 3 Study
December 6, 2010
·
7 min read
Pharm Country
MabCure, Inc. Completes 23.1 Million Australian Dollar Private Placement
December 6, 2010
·
6 min read
Drug Development
Celgene International Sárl Release: Phase III Study Evaluating REVLIMID(R) in Patients with High-Risk Smoldering Multiple Myeloma Reported Statistically Significant Reduction in Risk of Disease Progression
December 6, 2010
·
1 min read
Previous
4 of 20
Next
